| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d94d987d19ec840c3e33f9913c49005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fcb45e3cb535e5dbede8d6587afe0ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_271480a5c97eec04daf2399af96b3f6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42acd8538be863471d44a31fdceedaab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 |
| filingDate |
2007-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e86e37356b04ed3602a862b68b8c7eca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085c41d82836ca7a90d007aae23cde96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d036f097aad68b8d84f651df7a30949 |
| publicationDate |
2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008054214-A2 |
| titleOfInvention |
Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction |
| abstract |
The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha- androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014055142-A |
| priorityDate |
2006-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |